Preparation ''CC'' Cat's claw® (Tablets, Capsules) Instructions for Use
ATC Code
V30 (Not assigned)
Active Substance
Cat’s Claw bark extract
Clinical-Pharmacological Group
Herbal preparation with anti-inflammatory action
Pharmacotherapeutic Group
Herbal remedy
Pharmacological Action
A herbal remedy that has anti-inflammatory, antispasmodic, and antioxidant effects.
Indications
Use as part of combination therapy for the following conditions.
- Metabolic and joint disorders: arthritis, arthrosis, and rheumatoid arthritis.
- Gastrointestinal tract diseases: gastritis and colitis.
- Urinary system diseases: cystitis and pyelonephritis.
ICD codes
| ICD-10 code | Indication |
| K29 | Gastritis and duodenitis |
| K52.9 | Noninfective gastroenteritis and colitis, unspecified |
| M05 | Seropositive rheumatoid arthritis |
| M13.9 | Arthritis, unspecified |
| M15 | Polyosteoarthritis |
| M19.9 | Unspecified arthrosis |
| N30 | Cystitis |
| N10 | Acute tubulointerstitial nephritis (acute pyelonephritis) |
| N11 | Chronic tubulointerstitial nephritis (chronic pyelonephritis) |
| ICD-11 code | Indication |
| DA42.Z | Gastritis, unspecified |
| DA51.Z | Duodenitis, unspecified |
| DA7Z | Diseases of stomach or duodenum, unspecified |
| DA90.0 | Syndromic diarrhea |
| DE2Z | Diseases of the digestive system, unspecified |
| FA05 | Polyosteoarthritis |
| FA0Z | Osteoarthritis, unspecified |
| FA20.0 | Seropositive rheumatoid arthritis |
| FA2Z | Inflammatory arthropathies, unspecified |
| GB50 | Acute tubulo-interstitial nephritis |
| GB51 | Acute pyelonephritis |
| GB55.Z | Chronic tubulo-interstitial nephritis, unspecified |
| GB5Z | Renal tubulo-interstitial diseases, unspecified |
| GC00.Z | Cystitis, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally as an extract. Take the preparation three times daily, approximately 30 minutes before meals.
The standard course of treatment is 3 months. Extend the treatment duration based on clinical evaluation and patient response if necessary.
Adverse Reactions
Monitor for allergic reactions, which are possible following administration.
Discontinue use immediately and initiate appropriate therapy if any signs of hypersensitivity appear.
Drug Interactions
Exercise caution with concomitant use of immunosuppressants due to potential for reduced therapeutic efficacy.
Consult a healthcare professional before combining with other medications, as this herbal remedy may interact with drugs metabolized by cytochrome P450 enzymes.
Contraindications
Do not administer under the following conditions.
- Hypersensitivity to the herbal remedy or any of its components.
- Pregnancy and lactation (breastfeeding).
- Condition after organ transplantation due to potential immunostimulatory effects.
Overdose
No specific antidote is known. In case of suspected overdose, immediately discontinue the preparation.
Initiate symptomatic and supportive treatment. Gastric lavage and administration of activated charcoal may be considered if ingestion was recent.
Use in Pregnancy and Lactation
Contraindicated during pregnancy and lactation.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Capsules 20 mg: 45 or 100 pcs.
Marketing Authorization Holder
Laboratorios Induquimica, S.A. (Peru)
Dosage Form
 |
Preparation ”CC” Cat’s claw® | Capsules 20 mg: 45 or 100 pcs. |
Dosage Form, Packaging, and Composition
Capsules hard gelatin, cylindrical in shape with hemispherical ends; the capsule body is white, the cap is green; the capsule contents are a powder from pinkish-gray to light brown in color, with a faint specific odor.
| 1 caps. | |
| Dry extract of Cat’s Claw bark | 20 mg |
| Sum of alkaloids calculated as mitraphylline | 0.8% |
Excipients: galactopyranosyl dextrose monohydrate – 191.4 mg, magnesium silicate – 15 mg, magnesium stearate – 1.5 mg, colloidal silicon dioxide – 2.1 mg.
Composition of the capsule body: gelatin – 98.5%, titanium dioxide – 1.5%.
Composition of the capsule cap: gelatin – 98%, brilliant blue FCF dye (E133) – 0.25%, yellow iron oxide dye (E172) – 0.25%, titanium dioxide – 1.5%.
45 pcs. – polyethylene bottles.
10 pcs. – blisters (10) – cardboard packs.
Film-coated tablets 20 mg: 45 or 100 pcs.
Marketing Authorization Holder
Laboratorios Induquimica, S.A. (Peru)
Dosage Form
|
Preparation ”CC” Cat’s claw® | Film-coated tablets 20 mg: 45 or 100 pcs. |
Dosage Form, Packaging, and Composition
Film-coated tablets, transparent, from light brown to brown in color with inclusions, round in shape, odor faint, specific.
| 1 tab. | |
| Dry extract of Cat’s Claw bark | 20 mg |
| Sum of alkaloids calculated as mitraphylline | 0.8% |
Excipients: corn starch – 143.06 mg, sodium carboxymethyl starch – 3.4 mg, colloidal silicon dioxide – 3.4 mg, sodium benzoate – 0.14 mg.
Composition of the coating: hypromellose – 4.25 mg, propylene glycol – 0.001 mg, water – 0.055 mg.
10 pcs. – contour cell packs (10) – cardboard packs.
45 pcs. – polyethylene bottles (1) – cardboard packs.
![Preparation ''CC'' Cat's claw® [Tablets, Capsules] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Preparation ''CC'' Cat's claw® [Tablets, Capsules] 2")